¼¼°èÀÇ À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¸ðµåº°, ¿ëµµº°, ¹æ¹ýº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2024-2030³â)
Gene Delivery Technologies Market Size, Share & Trends Analysis Report By Mode (AAV, Lentivirus, Retrovirus), By Application (Gene Therapy, Cell Therapy), By Method (Ex-vivo, In-vivo), By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1553571
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 100 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,194,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,571,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,325,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 102¾ï 7,000¸¸ ´Þ·¯¿¡ À̸£·¶À¸¸ç, 2024-2030³â CAGRÀº 11.4%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¹ÙÀÌ·¯½º º¤ÅÍÀÇ ±â¼úÀû Áøº¸, ÷´Ü Ä¡·á ÆÄÀÌÇÁ¶óÀÎ Áõ°¡, ÷´Ü Ä¡·á Á¦Ç°ÀÇ ±ÔÁ¦ ´ç±¹¿¡ ÀÇÇÑ ½ÂÀÎ °Ç¼ö Áõ°¡°¡ ½ÃÀåÀÇ ÁÖ¿ä ÃßÁø·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

À¯ÀüÀÚ º¯È­¿¡ ´ëÇÑ ¸î °¡Áö »õ·Î¿î µµ±¸°¡ µµÀÔµÇ¾î °úÇа谡 À¯Àüü ¼öÁØ¿¡¼­ Áúº´ÀÇ º¹À⼺À» ¹àÈ÷±â ½¬¿öÁö°í »õ·Î¿î À¯ÀüÀÚ Àü´Þ Á¢±Ù¹ýÀÇ ÃâÇöÀ¸·Î À̾îÁý´Ï´Ù. °Ô´Ù°¡ °í±Þ Ä¡·á¸¦ ÅëÇØ ¾ÏÀ̳ª ¾ËÃ÷ÇÏÀ̸Ӻ´ µîÀÇ ¸¸¼º Áúȯ°ú ½Î¿ì±â À§ÇØ ¹ÙÀÌ·¯½º³ª ºñ¹ÙÀÌ·¯½º º¤Å͸¦ Æ÷ÇÔÇÑ ÀÓ»óÀûÀ¸·Î ÀûÀýÇÑ º¤Å͸¦ °³¹ßÇÏ´Â ¿¬±¸°¡ ÁøÇàµÇ°í ÀÖ¾î ½ÃÀåÀÇ ¼öÀÍ¿¡ ¹ÚÂ÷¸¦ °¡ÇÑ´Ù ÀÖ½À´Ï´Ù.

´Ù¾çÇÑ À¯ÀüÀÚ Àü´Þ ¹æ¹ýÀÇ ¿¬±¸°³¹ß¡¤Á¦Á¶¸¦ Áö¿øÇϱâ À§ÇÑ ÀÌ ºÎ¹®¿¡ ´ëÇÑ ÅõÀÚ¿Í ´ëÃâ Áõ°¡´Â ¼öÀÍÀÇ ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ÇöÀç À¯ÀüÀÚ ¹× ¼¼Æ÷ Ä¡·á ÇÁ·Î±×·¥ÀÇ ¾à 70%´Â ¹ÙÀÌ·¯½º º¤Å͸¦ ±â¹ÝÀ¸·Î »ý¹°ÇÐÀû Àü´Þ ±â¼úÀÇ À¯±â ¼öÀÍ ¼ºÀåÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¿î¿µ ±â¾÷Àº ¹ÙÀÌ·¯½º º¤ÅÍÀÇ »ý»ê ´É·ÂÀ» È®´ëÇÏ°í ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù.

ÇÇÁö¿ÀÄɹÌÄ® À¯ÀüÀÚ Àü´Þ Á¢±Ù¹ý¿¡¼­ÀÇ ºñÁî´Ï½º ±âȸÀÇ È®´ë¸¦ °í·ÁÇÏ¿©, ÁÖ¿ä ÁøÃâ±â¾÷Àº ºñÁî´Ï½º Á¸À縦 ³ôÀ̱â À§ÇØ ÁýÁßÀûÀÎ ³ë·ÂÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ³ª³ëÀÔÀÚ´Â ±×°ÍÀÇ Á¶Àý°¡´ÉÇÑ ÇüÅ ¹× »ý¹°ÇÐÀû °Åµ¿¿¡ ÀÇÇØ ÀÓ»ó »ç¿ëÀ» À§ÇÑ À¯¸ÁÇÑ Â÷·®À¸·Î¼­ ±× È¿À²¼ºÀÌ ÀÔÁõµÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÅÈï±¹ ½ÃÀåÀÇ ¹ßÀüÀº ¾ÕÀ¸·Î ¼ö³â°£ ÀÌ ½ÃÀåÀÇ ¼öÀÍ ¼ºÀåÀ» °¡¼Ó½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¼¼°èÀÇ À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀå : ¸ðµåº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¼¼°èÀÇ À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀå : ¿ëµµº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¼¼°èÀÇ À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀå : ¹æ¹ýº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¼¼°èÀÇ À¯ÀüÀÚ Àü´Þ ±â¼ú ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå °æÀï ±¸µµ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Gene Delivery Technologies Market Growth & Trends:

The global gene delivery technologies market size is expected to reach USD 10.27 billion by 2030, expanding at a CAGR of 11.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Technological advancements in viral vectors, a growing pipeline of advanced therapies, and a rising number of regulatory approvals for advance therapy products are some key driving forces of the market.

Several novel tools are being introduced for genetic alterations that have facilitated the scientific community to delineate the disease intricacies at the genomic level, leading to the emergence of novel gene delivery approaches. Furthermore, ongoing research to develop clinically relevant vectors including viral and non-viral vectors to combat chronic illnesses such as cancer, Alzheimer's, and others through advanced therapies is spurring the market revenue.

An increase in investment and financing in the space to support the research, development, and manufacturing of various modes of gene transfer further accelerates the revenue growth. Currently, around 70% of gene and cell therapy programs are based on viral vectors leading to organic revenue growth for biological delivery technologies. The operating players are investing significantly to scale up their viral vector manufacturing capability and meet the growing demand.

Considering growing opportunities in physio-chemical gene delivery approaches, key players are making focused efforts to boost their business presence. For instance, nanoparticles have proven their efficiency as promising vehicles for clinical usage owing to their tunable morphology, and biological behaviors. Such ongoing developments in the space are anticipated to accelerate revenue growth in this market in the coming years.

Gene Delivery Technologies Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Global Gene Delivery Technology Market Variables, Trends, & Scope

Chapter 4. Global Gene Delivery Technology Market: Mode Estimates & Trend Analysis

Chapter 5. Global Gene Delivery Technology Market: Application Estimates & Trend Analysis

Chapter 6. Global Gene Delivery Technology Market: Method Estimates & Trend Analysis

Chapter 7. Global Gene Delivery Technology Market: Regional Estimates & Trend Analysis

Chapter 8. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â